Form 144: Proposed sale of 1,365 Common shares

Morgan Stanley Smith Barney LLC lists proposed sales of Common shares in a Form 144 notice.

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC lists proposed sales of Common shares in a Form 144 notice. The filing shows a proposed sale tied to an exercise of stock options dated 03/19/2026 for 1,365 shares and restricted stock units dated 12/01/2025 for 96 shares.

Insights

Securities Compliance Counsel

Form 144 reports proposed resale of Common shares following option exercise and RSU vesting.

The excerpt lists a proposed sale linked to an exercise of stock options on 03/19/2026 for 1,365 shares and a separate item for 96 restricted stock units dated 12/01/2025. The filing records the method as cash.

These entries are a compliance notice of intent to sell under applicable resale rules; timing and disposition details beyond the listed dates are not provided in the excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does STOK's Form 144 disclose about proposed sales?

The Form 144 lists proposed sales of Common shares tied to an option exercise on 03/19/2026 for 1,365 shares and 96 restricted stock units dated 12/01/2025, filed as a resale notice.

Who is the filer on the STOK Form 144?

The filing names Morgan Stanley Smith Barney LLC Executive Financial Services in the issuer/filer information section, associated with the resale notice of Common shares.

What transaction types are shown in the STOK excerpt?

The excerpt shows an Exercise of Stock Options entry (dated 03/19/2026) and a Restricted Stock Units entry (dated 12/01/2025), both relating to Common shares.

How many shares are cited for the option exercise and RSUs in the STOK excerpt?

The excerpt cites 1,365 shares associated with the option exercise on 03/19/2026 and 96 shares tied to restricted stock units dated 12/01/2025.

Does the excerpt state how the proceeds will be handled?

The excerpt lists the option exercise method as Cash for the Common shares; no further cash‑flow allocation or use of proceeds detail is shown in the provided text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/19/2026 - 04:19 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001780088
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	STOKE THERAPEUTICS INC
SEC File Number	001-38938
Address of Issuer	45 Wiggins Ave Bedford MASSACHUSETTS 01730
Phone	7814308200
Name of Person for Whose Account the Securities are To Be Sold	BARUCH S. TICHO
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1461	45320.22	59150790	03/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/19/2026	Exercise of Stock Options	Issuer			1365	03/19/2026	Cash
Common	12/01/2025	Restricted Stock Units	Issuer			96	12/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	03/19/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/19/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ BARUCH S. TICHO
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)